IBDEI022 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2201,2)
 ;;=^303467
 ;;^UTILITY(U,$J,358.3,2202,0)
 ;;=V62.0^^21^165^40
 ;;^UTILITY(U,$J,358.3,2202,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2202,1,2,0)
 ;;=2^V62.0
 ;;^UTILITY(U,$J,358.3,2202,1,5,0)
 ;;=5^UNEMPLOYMENT
 ;;^UTILITY(U,$J,358.3,2202,2)
 ;;=^123545
 ;;^UTILITY(U,$J,358.3,2203,0)
 ;;=V65.49^^21^165^30
 ;;^UTILITY(U,$J,358.3,2203,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2203,1,2,0)
 ;;=2^V65.49
 ;;^UTILITY(U,$J,358.3,2203,1,5,0)
 ;;=5^OTHER SPECIFIED COUNSELING
 ;;^UTILITY(U,$J,358.3,2203,2)
 ;;=^303471
 ;;^UTILITY(U,$J,358.3,2204,0)
 ;;=V58.61^^21^165^17
 ;;^UTILITY(U,$J,358.3,2204,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2204,1,2,0)
 ;;=2^V58.61
 ;;^UTILITY(U,$J,358.3,2204,1,5,0)
 ;;=5^L/T (CURRENT) USE - ANTICOAG
 ;;^UTILITY(U,$J,358.3,2204,2)
 ;;=^303459
 ;;^UTILITY(U,$J,358.3,2205,0)
 ;;=V58.62^^21^165^19
 ;;^UTILITY(U,$J,358.3,2205,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2205,1,2,0)
 ;;=2^V58.62
 ;;^UTILITY(U,$J,358.3,2205,1,5,0)
 ;;=5^L/T (CURRENT) USE ANTIBIOTIC
 ;;^UTILITY(U,$J,358.3,2205,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,2206,0)
 ;;=V58.63^^21^165^21
 ;;^UTILITY(U,$J,358.3,2206,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2206,1,2,0)
 ;;=2^V58.63
 ;;^UTILITY(U,$J,358.3,2206,1,5,0)
 ;;=5^LNG USE ANTIPLTE/THRMBTC
 ;;^UTILITY(U,$J,358.3,2206,2)
 ;;=^329978
 ;;^UTILITY(U,$J,358.3,2207,0)
 ;;=V58.64^^21^165^22
 ;;^UTILITY(U,$J,358.3,2207,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2207,1,2,0)
 ;;=2^V58.64
 ;;^UTILITY(U,$J,358.3,2207,1,5,0)
 ;;=5^LONG-TERM ANTI-INFLAMTRY
 ;;^UTILITY(U,$J,358.3,2207,2)
 ;;=^329979
 ;;^UTILITY(U,$J,358.3,2208,0)
 ;;=V58.65^^21^165^25
 ;;^UTILITY(U,$J,358.3,2208,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2208,1,2,0)
 ;;=2^V58.65
 ;;^UTILITY(U,$J,358.3,2208,1,5,0)
 ;;=5^LONG-TERM USE STEROIDS
 ;;^UTILITY(U,$J,358.3,2208,2)
 ;;=^329980
 ;;^UTILITY(U,$J,358.3,2209,0)
 ;;=V58.66^^21^165^23
 ;;^UTILITY(U,$J,358.3,2209,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2209,1,2,0)
 ;;=2^V58.66
 ;;^UTILITY(U,$J,358.3,2209,1,5,0)
 ;;=5^LONG-TERM USE OF ASPIRIN
 ;;^UTILITY(U,$J,358.3,2209,2)
 ;;=^331584
 ;;^UTILITY(U,$J,358.3,2210,0)
 ;;=V58.67^^21^165^24
 ;;^UTILITY(U,$J,358.3,2210,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2210,1,2,0)
 ;;=2^V58.67
 ;;^UTILITY(U,$J,358.3,2210,1,5,0)
 ;;=5^LONG-TERM USE OF INSULIN
 ;;^UTILITY(U,$J,358.3,2210,2)
 ;;=^331585
 ;;^UTILITY(U,$J,358.3,2211,0)
 ;;=V58.69^^21^165^18
 ;;^UTILITY(U,$J,358.3,2211,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2211,1,2,0)
 ;;=2^V58.69
 ;;^UTILITY(U,$J,358.3,2211,1,5,0)
 ;;=5^L/T (CURRENT) USE - OTH MEDS
 ;;^UTILITY(U,$J,358.3,2211,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,2212,0)
 ;;=V65.40^^21^165^29
 ;;^UTILITY(U,$J,358.3,2212,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2212,1,2,0)
 ;;=2^V65.40
 ;;^UTILITY(U,$J,358.3,2212,1,5,0)
 ;;=5^OTH UNSP COUNSEL NOC
 ;;^UTILITY(U,$J,358.3,2212,2)
 ;;=^87449
 ;;^UTILITY(U,$J,358.3,2213,0)
 ;;=V65.41^^21^165^9
 ;;^UTILITY(U,$J,358.3,2213,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2213,1,2,0)
 ;;=2^V65.41
 ;;^UTILITY(U,$J,358.3,2213,1,5,0)
 ;;=5^EXERCISE COUNSELING
 ;;^UTILITY(U,$J,358.3,2213,2)
 ;;=^303466
 ;;^UTILITY(U,$J,358.3,2214,0)
 ;;=V65.43^^21^165^4
 ;;^UTILITY(U,$J,358.3,2214,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2214,1,2,0)
 ;;=2^V65.43
 ;;^UTILITY(U,$J,358.3,2214,1,5,0)
 ;;=5^COUNSEL-INJURY PREVEN
 ;;^UTILITY(U,$J,358.3,2214,2)
 ;;=^303468
 ;;^UTILITY(U,$J,358.3,2215,0)
 ;;=V65.45^^21^165^5
 ;;^UTILITY(U,$J,358.3,2215,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2215,1,2,0)
 ;;=2^V65.45
 ;;^UTILITY(U,$J,358.3,2215,1,5,0)
 ;;=5^COUNSEL-OTH SEX TX DISEASES
 ;;^UTILITY(U,$J,358.3,2215,2)
 ;;=^303470
 ;;^UTILITY(U,$J,358.3,2216,0)
 ;;=V71.09^^21^166^1
 ;;^UTILITY(U,$J,358.3,2216,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2216,1,2,0)
 ;;=2^V71.09
 ;;^UTILITY(U,$J,358.3,2216,1,5,0)
 ;;=5^OBSERV-MENTAL COND NEC
 ;;^UTILITY(U,$J,358.3,2216,2)
 ;;=^295604
 ;;^UTILITY(U,$J,358.3,2217,0)
 ;;=99080^^22^167^7^^^^1
 ;;^UTILITY(U,$J,358.3,2217,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2217,1,2,0)
 ;;=2^99080
 ;;^UTILITY(U,$J,358.3,2217,1,3,0)
 ;;=3^SPECIAL REPORTS OR FORMS
 ;;^UTILITY(U,$J,358.3,2218,0)
 ;;=97535^^22^167^6^^^^1
 ;;^UTILITY(U,$J,358.3,2218,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2218,1,2,0)
 ;;=2^97535
 ;;^UTILITY(U,$J,358.3,2218,1,3,0)
 ;;=3^SELF CARE MNGMENT TRAINING
 ;;^UTILITY(U,$J,358.3,2219,0)
 ;;=99366^^22^167^8^^^^1
 ;;^UTILITY(U,$J,358.3,2219,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2219,1,2,0)
 ;;=2^99366
 ;;^UTILITY(U,$J,358.3,2219,1,3,0)
 ;;=3^TEAM CONF W/PAT BY HC PRO
 ;;^UTILITY(U,$J,358.3,2220,0)
 ;;=A9279^^22^167^5^^^^1
 ;;^UTILITY(U,$J,358.3,2220,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2220,1,2,0)
 ;;=2^A9279
 ;;^UTILITY(U,$J,358.3,2220,1,3,0)
 ;;=3^MONITORING FEATURE/DEVICE NOC
 ;;^UTILITY(U,$J,358.3,2221,0)
 ;;=H0034^^22^167^4^^^^1
 ;;^UTILITY(U,$J,358.3,2221,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2221,1,2,0)
 ;;=2^H0034
 ;;^UTILITY(U,$J,358.3,2221,1,3,0)
 ;;=3^MED TRNG & SUPPORT PER 15MIN
 ;;^UTILITY(U,$J,358.3,2222,0)
 ;;=S9455^^22^167^1^^^^1
 ;;^UTILITY(U,$J,358.3,2222,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2222,1,2,0)
 ;;=2^S9455
 ;;^UTILITY(U,$J,358.3,2222,1,3,0)
 ;;=3^DIAB MANAGE TRN GROUP
 ;;^UTILITY(U,$J,358.3,2223,0)
 ;;=S9445^^22^167^2^^^^1
 ;;^UTILITY(U,$J,358.3,2223,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2223,1,2,0)
 ;;=2^S9445
 ;;^UTILITY(U,$J,358.3,2223,1,3,0)
 ;;=3^DIAB MANAGE TRN PER INDIV
 ;;^UTILITY(U,$J,358.3,2224,0)
 ;;=S9446^^22^167^3^^^^1
 ;;^UTILITY(U,$J,358.3,2224,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2224,1,2,0)
 ;;=2^S9446
 ;;^UTILITY(U,$J,358.3,2224,1,3,0)
 ;;=3^GROUP HEALTH EDUCATION
 ;;^UTILITY(U,$J,358.3,2225,0)
 ;;=S9445^^22^168^1^^^^1
 ;;^UTILITY(U,$J,358.3,2225,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2225,1,2,0)
 ;;=2^S9445
 ;;^UTILITY(U,$J,358.3,2225,1,3,0)
 ;;=3^PT EDUCATION NOC INDIVID
 ;;^UTILITY(U,$J,358.3,2226,0)
 ;;=99091^^22^169^1^^^^1
 ;;^UTILITY(U,$J,358.3,2226,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2226,1,2,0)
 ;;=2^99091
 ;;^UTILITY(U,$J,358.3,2226,1,3,0)
 ;;=3^COLLECT/REVIEW DATA FROM PT
 ;;^UTILITY(U,$J,358.3,2227,0)
 ;;=G0155^^22^170^1^^^^1
 ;;^UTILITY(U,$J,358.3,2227,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2227,1,2,0)
 ;;=2^G0155
 ;;^UTILITY(U,$J,358.3,2227,1,3,0)
 ;;=3^HOME VISIT BY CSW,EA 15 MIN
 ;;^UTILITY(U,$J,358.3,2228,0)
 ;;=90847^^22^171^1^^^^1
 ;;^UTILITY(U,$J,358.3,2228,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2228,1,2,0)
 ;;=2^90847
 ;;^UTILITY(U,$J,358.3,2228,1,3,0)
 ;;=3^FAMILY PSYTX W/PATIENT
 ;;^UTILITY(U,$J,358.3,2229,0)
 ;;=90849^^22^171^3^^^^1
 ;;^UTILITY(U,$J,358.3,2229,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2229,1,2,0)
 ;;=2^90849
 ;;^UTILITY(U,$J,358.3,2229,1,3,0)
 ;;=3^MULTIPLE FAMILY GROUP PSYTX
 ;;^UTILITY(U,$J,358.3,2230,0)
 ;;=90853^^22^171^2^^^^1
 ;;^UTILITY(U,$J,358.3,2230,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2230,1,2,0)
 ;;=2^90853
 ;;^UTILITY(U,$J,358.3,2230,1,3,0)
 ;;=3^GROUP PSYCHOTHERAPY
 ;;^UTILITY(U,$J,358.3,2231,0)
 ;;=90832^^22^171^4^^^^1
 ;;^UTILITY(U,$J,358.3,2231,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2231,1,2,0)
 ;;=2^90832
 ;;^UTILITY(U,$J,358.3,2231,1,3,0)
 ;;=3^PSYTX PT OR FAMILY 17-32 MIN
 ;;^UTILITY(U,$J,358.3,2232,0)
 ;;=90834^^22^171^5^^^^1
 ;;^UTILITY(U,$J,358.3,2232,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2232,1,2,0)
 ;;=2^90834
 ;;^UTILITY(U,$J,358.3,2232,1,3,0)
 ;;=3^PSYTX PT OR FAMILY 38-52 MIN
 ;;^UTILITY(U,$J,358.3,2233,0)
 ;;=90837^^22^171^6^^^^1
 ;;^UTILITY(U,$J,358.3,2233,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2233,1,2,0)
 ;;=2^90837
 ;;^UTILITY(U,$J,358.3,2233,1,3,0)
 ;;=3^PSYTX PT OR FAMILY 53+ MIN
 ;;^UTILITY(U,$J,358.3,2234,0)
 ;;=T1016^^22^172^1^^^^1
 ;;^UTILITY(U,$J,358.3,2234,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2234,1,2,0)
 ;;=2^T1016
 ;;^UTILITY(U,$J,358.3,2234,1,3,0)
 ;;=3^CASE MANAGEMENT EA 15MIN
 ;;^UTILITY(U,$J,358.3,2235,0)
 ;;=V71.89^^23^173^1
 ;;^UTILITY(U,$J,358.3,2235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2235,1,3,0)
 ;;=3^ENROLLMENT IN CCHT PROGRAM
 ;;^UTILITY(U,$J,358.3,2235,1,4,0)
 ;;=4^V71.89
 ;;^UTILITY(U,$J,358.3,2235,2)
 ;;=^322082
 ;;^UTILITY(U,$J,358.3,2236,0)
 ;;=A4220^^24^174^1^^^^1
 ;;^UTILITY(U,$J,358.3,2236,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2236,1,1,0)
 ;;=1^A4220
 ;;^UTILITY(U,$J,358.3,2236,1,3,0)
 ;;=3^Infusion Pump Refill Kit
 ;;^UTILITY(U,$J,358.3,2237,0)
 ;;=99195^^24^175^32^^^^1
 ;;^UTILITY(U,$J,358.3,2237,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2237,1,1,0)
 ;;=1^99195
 ;;^UTILITY(U,$J,358.3,2237,1,3,0)
 ;;=3^Therapeutic Phlebotomy
 ;;^UTILITY(U,$J,358.3,2238,0)
 ;;=96450^^24^175^18^^^^1
 ;;^UTILITY(U,$J,358.3,2238,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2238,1,1,0)
 ;;=1^96450
 ;;^UTILITY(U,$J,358.3,2238,1,3,0)
 ;;=3^Chemotherapy, Into CNS
 ;;^UTILITY(U,$J,358.3,2239,0)
 ;;=96420^^24^175^8^^^^1
 ;;^UTILITY(U,$J,358.3,2239,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2239,1,1,0)
 ;;=1^96420
 ;;^UTILITY(U,$J,358.3,2239,1,3,0)
 ;;=3^Chemo,IA Push
 ;;^UTILITY(U,$J,358.3,2240,0)
 ;;=96422^^24^175^6^^^^1
 ;;^UTILITY(U,$J,358.3,2240,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2240,1,1,0)
 ;;=1^96422
 ;;^UTILITY(U,$J,358.3,2240,1,3,0)
 ;;=3^Chemo,IA Infus,Init hr
 ;;^UTILITY(U,$J,358.3,2241,0)
 ;;=96405^^24^175^3^^^^1
 ;;^UTILITY(U,$J,358.3,2241,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2241,1,1,0)
 ;;=1^96405
 ;;^UTILITY(U,$J,358.3,2241,1,3,0)
 ;;=3^Chemo Admin Intralesional
 ;;^UTILITY(U,$J,358.3,2242,0)
 ;;=96440^^24^175^5^^^^1
 ;;^UTILITY(U,$J,358.3,2242,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2242,1,1,0)
 ;;=1^96440
 ;;^UTILITY(U,$J,358.3,2242,1,3,0)
 ;;=3^Chemo Admin, Pleural Cavity
 ;;^UTILITY(U,$J,358.3,2243,0)
 ;;=96542^^24^175^12.5^^^^1
 ;;^UTILITY(U,$J,358.3,2243,1,0)
 ;;=^358.31IA^3^2
